EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis
Author:
Affiliation:
1. Pituitary Center, Department of Medicine and
2. Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048
Publisher
The Endocrine Society
Subject
Endocrinology, Diabetes and Metabolism
Link
http://academic.oup.com/jes/article-pdf/1/2/127/10252310/js.2016-1053.pdf
Reference38 articles.
1. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement;Biller;J Clin Endocrinol Metab,2008
2. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy;Ben-Shlomo;J Clin Endocrinol Metab,2009
3. Treatment of pituitary-dependent Cushing’s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial;Boscaro;J Clin Endocrinol Metab,2009
4. A 12-month phase 3 study of pasireotide in Cushing’s disease;Colao;N Engl J Med,2012
5. Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing’s disease;Newell-Price;J Clin Endocrinol Metab,2014
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing’s disease and a systematic review of the literature;BMC Endocrine Disorders;2024-06-11
2. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease;Archives of Medical Research;2023-12
3. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas;Pituitary;2023-08-29
4. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas;2023-07-03
5. An evaluation of pharmacological options for Cushing’s disease: what are the state-of-the-art options?;Expert Opinion on Pharmacotherapy;2023-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3